Skip to content
EvidenceHelixEvidenceLib · Scientific Encyclopedia
⌘ K

Scientific library

EvidenceLib encyclopediaAll articles A–Z2,100Open textbooks2Cancer study catalog458How it is made

My workspace this browser

Saved pages0Notes & annotations0

Recently viewed

Explore by field

Cancer and Oncology107Genetics and Genomics95Neuroscience110Cardiovascular Medicine105Immunology90Pharmacology99Molecular Biology100Infectious Diseases102Rare and Inherited Diseases106Clinical Research98Anatomy and Physiology542Drugs and Chemicals546
Plans & pricingCompare EvidenceHelix workspace plans
Library›EvidenceLib›Molecular Biology›Interphase
Explore more with EvidenceHelix Workspace

Compare studies, analyze evidence and create research reports with premium tools.

Explore Researcher plans

Research reading room

Interphase

Molecular Biology · NLM MeSH · updated 2026-10-29 · version 1

Citations verified against PubMedNot yet clinician-reviewed10 referencesApproximately 4 min read

The interval between two successive cell divisions during which the chromosomes are not individually distinguishable.

Table of Contents

1. Definition2. Research landscape3. Reading the evidence4. Open-access studies5. Key reviews6. References7. About this article

Definition and research guide

This page combines a MeSH definition, publication statistics and selected research abstracts. It is a starting point for reading the literature, not a medical textbook or a systematic evidence review.

Content available: 4 complete abstracts (683 words), 10 references. Full article text is not stored or reproduced here; follow the PMID, DOI or PMC links to read the original sources and their access terms.

Definition

The interval between two successive cell divisions during which the chromosomes are not individually distinguishable. It is composed of the G phases (G1 phase; G0 phase; G2 phase) and S phase (when DNA replication occurs).

Definition: NLM Medical Subject Headings (MeSH) scope note (Public domain (U.S. National Library of Medicine); attribution requested). View the MeSH record.

Also known as: Interphases.

Where it fits in the MeSH classification

Broader topics
Cell Cycle
Narrower topics
G1 Phase; G2 Phase; Resting Phase, Cell Cycle; S Phase

Related concepts

  • Cell Division
  • Chromosomes
  • Phase

Research landscape

PubMed indexes 36,368 records tagged with the MeSH heading “Interphase” (counts retrieved 2026-10-29). 2,606 of them (7.2%) were published from 2020 onward, and the busiest period so far is through 1999 with 11,393 records.

Reviews account for 1,613 records (4.4%) and meta-analyses for 3. Randomized controlled trials number 37 (0.1%) as a share of all records on the topic. Randomized trials make up only a small share of this literature, so much of what is known comes from laboratory, observational or descriptive work.

PubMed records by publication periodthrough 1999: 11,393 records; 2000-2009: 10,998 records; 2010-2019: 11,371 records; 2020 onward: 2,606 records11,393through 199910,9982000-200911,3712010-20192,6062020 onward
Records in PubMed indexed with this heading, by publication period. Real counts from NCBI E-utilities; the final period covers only part of the current year. Volume reflects how much has been published, not how strong the evidence is.
Show the data
PeriodRecords
through 199911,393
2000-200910,998
2010-201911,371
2020 onward2,606
Share of records by publication typeReviews: 4.4 percent; Meta-analyses: 0.0 percent; Randomized controlled trials: 0.1 percentReviews4.4% (1,613)Meta-analyses0.0% (3)Randomized controlled trials0.1% (37)
Share of all PubMed records on this heading that carry each publication type. Types overlap with other records, so the shares do not sum to 100%.
Publication-type chart data
Publication types among 36,368 PubMed records
TypeRecordsShare
Reviews1,6134.4%
Meta-analyses30.0%
Randomized controlled trials370.1%

Method: PubMed query "Interphase"[MeSH Terms] with publication-type and date filters, retrieved 2026-10-29.

Reading the evidence in molecular biology

Molecular biology establishes mechanisms through controlled experiments, often in simplified systems such as purified proteins, cultured cells or model organisms. Such work can show what is possible in a defined system, but whether a pathway matters in a whole organism or in human disease needs further evidence. Check the experimental system, whether findings were reproduced by independent groups, and whether the authors tested the mechanism directly or inferred it from correlation.

Evidence from open-access studies

These open-access studies come from PubMed’s best-match results for this heading (papers whose main topic it is), ranked here by citation count, with one recent addition. Each abstract is reproduced in full under its recorded open licence so that you can read the authors’ own words. They illustrate the literature; they are not a systematic summary of it. Citation counts measure attention, not reliability or clinical benefit.

Study comparison — selected abstracts, not a systematic review
Study / authorsYearSource label / designEurope PMC citationsLicence / source
Senescence in Post-Mitotic Cells: A Driver of Aging?
von Zglinicki T, Wan T, Miwa S
2021Review article
Design not recorded in structured metadata
146cc by
PMID 32164429 · DOI · PMC7821432
Genetic instability from a single S phase after whole-genome duplication
Gemble S, Wardenaar R, Keuper K, Srivastava N, Nano M, Macé AS, et al.
2022Research article
Design not recorded in structured metadata
130cc by
PMID 35355016 · DOI · PMC8986533
Stress-mediated exit to quiescence restricted by increasing persistence in CDK4/6 activation
Yang HW, Cappell SD, Jaimovich A, Liu C, Chung M, Daigh LH, et al.
2020Research article
Design not recorded in structured metadata
89cc0
PMID 32255427 · DOI · PMC7213986
Interphase chromosome conformation is specified by distinct folding programmes inherited through mitotic chromosomes or the cytoplasm
Schooley A, Venev SV, Aksenova V, Lehman JW, Navarrete E, Pai AA, et al.
2026Research article
Design not recorded in structured metadata
23cc by
PMID 41429936 · DOI · PMC12807859

Senescence in Post-Mitotic Cells: A Driver of Aging? [1]

Review article von Zglinicki T, Wan T, Miwa S · · 2021 · cited 146 times (Europe PMC)

Abstract reading summary — source excerpts
Opening excerpt
Significance: Cell senescence was originally defined by an acute loss of replicative capacity and thus believed to be restricted to proliferation-competent cells.
Closing excerpt
34, 308-323.
Interpretation limits
Verbatim excerpts from the authors’ abstract; the closing excerpt may describe a finding, limitation or recommendation. Design, population, effect size and uncertainty have not been independently extracted or appraised. Read the complete abstract and linked paper before interpreting the findings.
Read complete abstract (212 words)

Significance: Cell senescence was originally defined by an acute loss of replicative capacity and thus believed to be restricted to proliferation-competent cells. More recently, senescence has been recognized as a cellular stress and damage response encompassing multiple pathways or senescence domains, namely DNA damage response, cell cycle arrest, senescence-associated secretory phenotype, senescence-associated mitochondrial dysfunction, autophagy/mitophagy dysfunction, nutrient and stress signaling, and epigenetic reprogramming. Each of these domains is activated during senescence, and all appear to interact with each other. Cell senescence has been identified as an important driver of mammalian aging. Recent Advances: Activation of all these senescence domains has now also been observed in a wide range of post-mitotic cells, suggesting that senescence as a stress response can occur in nondividing cells temporally uncoupled from cell cycle arrest. Here, we review recent evidence for post-mitotic cell senescence and speculate about its possible relevance for mammalian aging. Critical Issues: Although a majority of senescence domains has been found to be activated in a range of post-mitotic cells during aging, independent confirmation of these results is still lacking for most of them. Future Directions: To define whether post-mitotic senescence plays a significant role as a driver of aging phenotypes in tissues such as brain, muscle, heart, and others. Antioxid. Redox Signal. 34, 308-323.

Abstract reproduced from the open-access article under the recorded cc by licence; © the authors. PMID 32164429 · DOI · PMC7821432

Genetic instability from a single S phase after whole-genome duplication [2]

Research article Gemble S, Wardenaar R, Keuper K, Srivastava N, Nano M, Macé AS, et al. · · 2022 · cited 130 times (Europe PMC)

Abstract reading summary — source excerpts
Opening excerpt
Diploid and stable karyotypes are associated with health and fitness in animals.
Closing excerpt
These findings provide an explanation for the genetic instability landscape that favours tumorigenesis after tetraploidization.
Interpretation limits
Verbatim excerpts from the authors’ abstract; the closing excerpt may describe a finding, limitation or recommendation. Design, population, effect size and uncertainty have not been independently extracted or appraised. Read the complete abstract and linked paper before interpreting the findings.
Read complete abstract (172 words)

Diploid and stable karyotypes are associated with health and fitness in animals. By contrast, whole-genome duplications-doublings of the entire complement of chromosomes-are linked to genetic instability and frequently found in human cancers1-3. It has been established that whole-genome duplications fuel chromosome instability through abnormal mitosis4-8; however, the immediate consequences of tetraploidy in the first interphase are not known. This is a key question because single whole-genome duplication events such as cytokinesis failure can promote tumorigenesis9. Here we find that human cells undergo high rates of DNA damage during DNA replication in the first S phase following induction of tetraploidy. Using DNA combing and single-cell sequencing, we show that DNA replication dynamics is perturbed, generating under- and over-replicated regions. Mechanistically, we find that these defects result from a shortage of proteins during the G1/S transition, which impairs the fidelity of DNA replication. This work shows that within a single interphase, unscheduled tetraploid cells can acquire highly abnormal karyotypes. These findings provide an explanation for the genetic instability landscape that favours tumorigenesis after tetraploidization.

Abstract reproduced from the open-access article under the recorded cc by licence; © the authors. PMID 35355016 · DOI · PMC8986533

Stress-mediated exit to quiescence restricted by increasing persistence in CDK4/6 activation [3]

Research article Yang HW, Cappell SD, Jaimovich A, Liu C, Chung M, Daigh LH, et al. · · 2020 · cited 89 times (Europe PMC)

Abstract reading summary — source excerpts
Opening excerpt
Mammalian cells typically start the cell-cycle entry program by activating cyclin-dependent protein kinase 4/6 (CDK4/6).
Closing excerpt
Together, our study reveals a regulation of G1 length by temporary inactivation of CDK4/6 activity after mitosis, and a progressively increasing persistence in CDK4/6 activity that restricts cells from returning to quiescence as cells approach S phase.
Interpretation limits
Verbatim excerpts from the authors’ abstract; the closing excerpt may describe a finding, limitation or recommendation. Design, population, effect size and uncertainty have not been independently extracted or appraised. Read the complete abstract and linked paper before interpreting the findings.
Read complete abstract (150 words)

Mammalian cells typically start the cell-cycle entry program by activating cyclin-dependent protein kinase 4/6 (CDK4/6). CDK4/6 activity is clinically relevant as mutations, deletions, and amplifications that increase CDK4/6 activity contribute to the progression of many cancers. However, when CDK4/6 is activated relative to CDK2 remained incompletely understood. Here, we developed a reporter system to simultaneously monitor CDK4/6 and CDK2 activities in single cells and found that CDK4/6 activity increases rapidly before CDK2 activity gradually increases, and that CDK4/6 activity can be active after mitosis or inactive for variable time periods. Markedly, stress signals in G1 can rapidly inactivate CDK4/6 to return cells to quiescence but with reduced probability as cells approach S phase. Together, our study reveals a regulation of G1 length by temporary inactivation of CDK4/6 activity after mitosis, and a progressively increasing persistence in CDK4/6 activity that restricts cells from returning to quiescence as cells approach S phase.

Abstract reproduced from the open-access article under the recorded cc0 licence; © the authors. PMID 32255427 · DOI · PMC7213986

Interphase chromosome conformation is specified by distinct folding programmes inherited through mitotic chromosomes or the cytoplasm [4]

Research article Schooley A, Venev SV, Aksenova V, Lehman JW, Navarrete E, Pai AA, et al. · · 2026 · cited 23 times (Europe PMC)

Abstract reading summary — source excerpts
Opening excerpt
Identity-specific chromosome conformation must be re-established at each cell division.
Closing excerpt
The combined and interdependent action of chromosome-intrinsic and cytoplasmic inherited folding programmes determines the interphase chromatin conformation as cells exit mitosis.
Interpretation limits
Verbatim excerpts from the authors’ abstract; the closing excerpt may describe a finding, limitation or recommendation. Design, population, effect size and uncertainty have not been independently extracted or appraised. Read the complete abstract and linked paper before interpreting the findings.
Read complete abstract (149 words)

Identity-specific chromosome conformation must be re-established at each cell division. To uncover how interphase folding is inherited, we developed an approach that segregates chromosome-intrinsic mechanisms from those propagated through the cytoplasm during G1 nuclear reassembly. Inducible degradation of proteins essential for the establishment of nucleocytoplasmic transport during mitotic exit enabled analysis of folding programmes with distinct modes of inheritance. Here we show that genome compartmentalization is driven entirely by chromosome-intrinsic factors. In addition to conventional compartmental segregation, the chromosome-intrinsic folding programme leads to prominent genome-scale microcompartmentalization of mitotically bookmarked cis-regulatory elements. The microcompartment conformation forms transiently during telophase and is subsequently modulated by a second folding programme inherited through the cytoplasm in early G1. This programme includes cohesin-mediated loop extrusion and factors involved in transcription and RNA processing. The combined and interdependent action of chromosome-intrinsic and cytoplasmic inherited folding programmes determines the interphase chromatin conformation as cells exit mitosis.

Abstract reproduced from the open-access article under the recorded cc by licence; © the authors. PMID 41429936 · DOI · PMC12807859

Key reviews and meta-analyses

The most cited review-type papers among PubMed’s best-match results for this heading, listed with bibliographic details only. Follow the links for the full text and access terms.

  • Research article CDK inhibitors: positive and negative regulators of G1-phase progression [5]
    Sherr CJ, Roberts JM · Genes Dev · 1999 · cited 4,456 times (Europe PMC)
  • Research article G1 phase progression: cycling on cue [6]
    Sherr CJ · Cell · 1994 · cited 1,972 times (Europe PMC)
  • Research article PCNA, the maestro of the replication fork [7]
    Moldovan GL, Pfander B, Jentsch S · Cell · 2007 · cited 1,452 times (Europe PMC)
  • Research article Control of cell cycle transcription during G1 and S phases [8]
    Bertoli C, Skotheim JM, de Bruin RA · Nat Rev Mol Cell Biol · 2013 · cited 1,198 times (Europe PMC)
  • Research article Regulation of the G2/M transition by p53 [9]
    Taylor WR, Stark GR · Oncogene · 2001 · cited 1,163 times (Europe PMC)
  • Research article G1 cell-cycle control and cancer [10]
    Massagué J · Nature · 2004 · cited 917 times (Europe PMC)

References

  1. von Zglinicki T, Wan T, Miwa S. Senescence in Post-Mitotic Cells: A Driver of Aging?. . 2021. PMID 32164429 · DOI · PMC7821432
  2. Gemble S, Wardenaar R, Keuper K, Srivastava N, Nano M, Macé AS, et al.. Genetic instability from a single S phase after whole-genome duplication. . 2022. PMID 35355016 · DOI · PMC8986533
  3. Yang HW, Cappell SD, Jaimovich A, Liu C, Chung M, Daigh LH, et al.. Stress-mediated exit to quiescence restricted by increasing persistence in CDK4/6 activation. . 2020. PMID 32255427 · DOI · PMC7213986
  4. Schooley A, Venev SV, Aksenova V, Lehman JW, Navarrete E, Pai AA, et al.. Interphase chromosome conformation is specified by distinct folding programmes inherited through mitotic chromosomes or the cytoplasm. . 2026. PMID 41429936 · DOI · PMC12807859
  5. Sherr CJ, Roberts JM. CDK inhibitors: positive and negative regulators of G1-phase progression. Genes Dev. 1999. PMID 10385618 · DOI
  6. Sherr CJ. G1 phase progression: cycling on cue. Cell. 1994. PMID 7954821 · DOI
  7. Moldovan GL, Pfander B, Jentsch S. PCNA, the maestro of the replication fork. Cell. 2007. PMID 17512402 · DOI
  8. Bertoli C, Skotheim JM, de Bruin RA. Control of cell cycle transcription during G1 and S phases. Nat Rev Mol Cell Biol. 2013. PMID 23877564 · DOI · PMC4569015
  9. Taylor WR, Stark GR. Regulation of the G2/M transition by p53. Oncogene. 2001. PMID 11313928 · DOI
  10. Massagué J. G1 cell-cycle control and cancer. Nature. 2004. PMID 15549091 · DOI

About this article

Sources
NLM Medical Subject Headings (definition, synonyms); NCBI PubMed (counts, identifiers); Europe PMC (open-access abstracts and citation counts).
Verification
Every reference was resolved against PubMed on 2026-10-31; title, year and DOI matched.
Review state
automated source verified; no human expert review has been recorded yet.
Version
1, last updated 2026-10-29.

See how EvidenceLib is built. Spotted an error? Email support@evidencehelix.com.

Evidence strength

EvidenceHelix's computed view of the study designs behind this topic: how common meta-analyses, randomized trials and reviews are, how recent the literature is, and a plain-language reading. It describes the design mix of the literature. It is not a quality appraisal of any study, and it is not medical advice.

Included with the Researcher plan

Reading every article stays free. This computed view is part of the paid plans.

See plans Sign in

Your notes

Notes and highlights stay in this browser only; they are not sent to EvidenceHelix.

Related research topics

  • G2 PhaseMolecular Biology
  • S PhaseMolecular Biology
  • G1 PhaseMolecular Biology
  • Cell CycleMolecular Biology
  • Cell DivisionMolecular Biology
  • MitosisMolecular Biology

All 100 articles in Molecular Biology →

At a glance

36,368
PubMed records on this heading
7%
published since 2020
1,613
review articles
37
randomized trials
10
verified references below

Counts come from PubMed on 2026-10-29; they show how much has been written, not how strong the evidence is.

Related topics See all →

  • G2 PhaseMolecular Biology
  • S PhaseMolecular Biology
  • G1 PhaseMolecular Biology
  • Cell CycleMolecular Biology
  • Cell DivisionMolecular Biology

My notes & annotations (0)

Nothing yet. Select text and press Highlight, or write a note in the Notes tab. Stored in this browser only.

Sources

  • NLM MeSH record ↗
  • PubMed search used ↗

EvidenceLib is a research-education resource, not medical advice. It does not diagnose, prescribe or recommend starting, stopping or changing any treatment. Talk to a qualified clinician about your own situation. Methods, sources and licences · Legal · Support